National and Kapodistrian University of Athens
Μοριακή διάγνωση της μικρομεταστατικής νόσου στον καρκίνο μαστού
Abstract
dc:descriptionCirculating tumor cells represent an important biological link in the prevalence of breast cancer, between primary tumor and metastatic disease. CTCs have already been established as strong predictors of prognosis in patients with metastatic breast cancer. The expression of epithelial cancer marker CK-19 in 179 samples of patients with early breast cancer and we found out that the patients that were positive for mRNA of CK-19 were associates with disease free interval (P=0,0140) and overall survival (P=0,0510). Quantitative real-time PCR was developed for the transcription factor TWIST-1 and the gene HER-2. CTCs were detected concerning the expression of TWIST-1 in 12,5% of patients with early breast cancer, in 5.5% concerning the expression of HER-2 and in 11,1% in patients with verified metastasis. Quantitative multiplex real-time PCR was developed for the genes CK-19, MAGE A3, HER-2, PBGD. CTC’s were detected in patients with early breast cancer 42,2% for CK-19, 18,8% for MAGE A3, 12,5% for HER-2 and in patients with verified metastasis, 51,8% for CK-19, 14,8% for MAGE A3, 18,5% for HER-2.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Στρατή, Αρετή
- Strati, Areti
Subjects
dc:subject × 20- Καρκίνος μαστού
- Κυκλοφορούντα καρκινικά κύτταρα
- Μετάσταση καρκίνου
- Μονοπυρήνα κύτταρα περιφερικού αίματος
- Γονιδιακή έκφραση
- Επιθηλιακοί καρκινικοί δείκτες
- Πολλαπλή ποσοτική PCR
- Εμπλουτισμός με ανοσομαγνητικά σφαιρίδια
- Breast cancer
- Circulating tumor cells
- Metastasis
- Peripheral blood mononuclear cells
- Gene expression
- Epithelial cancer markers
- Multiplex quantitative PCR
- Enrichment with immunomagnetic beads
- Φυσικές Επιστήμες
- Χημεία
- Natural Sciences
- Chemical Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/26247